Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb 5:16:161-6.

Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas

Barbara Strzalka-Mrozik  1 , Agnieszka Stanik-Walentek, Malgorzata Kapral, Malgorzata Kowalczyk, Jolanta Adamska, Joanna Gola, Urszula Mazurek
Affiliations

Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas

Barbara Strzalka-Mrozik et al. Mol Vis. .

Abstract

Purpose: The aim of this study was to investigate transcriptional activities of genes encoding transforming growth factor (TGF)-beta isoforms in bullous keratopathy corneas.

Methods: The study group consisted of 45 patients with bullous keratopathy (22 females and 23 males). The control group included 45 corneal donors (21 females and 24 males). Quantification of TGF-beta1, TGF-beta2, and TGF-beta3 mRNAs was performed by real-time quantitative reverse transcription PCR (QRT-PCR).

Results: TGF-beta1, TGF-beta2, and TGF-beta3 mRNAs were detected in both normal and pseudophakic bullous keratopathy (PBK) corneas. We found significantly lower transcriptional activity of TGF-beta3 mRNA in bullous keratopathy corneas compared to normal tissues. TGF-beta1 and TGF-beta2 expressions were at the same level in both PBK and healthy corneas.

Conclusions: Downregulation of TGF-beta3 gene expression may play a significant role in molecular changes observed in bullous keratopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reverse transcription PCR products separated in 6% polyacrylamide gel. lane 1, marker of size pBR 322/BsuRI (MBI Fermentas, Vilnius, Lithuania); lane 2, transforming growth factor -β1 (152 base pair, bp); lane 3, transforming growth factor -β2 (201 bp); lane 4, transforming growth factor -β3 (121 bp); lane 5 glyceraldehyde-3-phosphate dehydrogenase (226 bp).
Figure 2
Figure 2
Transforming growth factor β in normal human corneas and pseudophakic bullous keratopathy corneas. The expression of transforming growth factor -β1, transforming growth factor -β2, and transforming growth factor -β3 isoforms in (A) normal human corneas (Kruskal–Wallis one-way analysis of variance test; p=0.0003) and (B) pseudophakic bullous keratopathy corneas (Kruskal–Wallis one-way analysis of variance test; p<0.0001). C: Comparison of transforming growth factor -β3 gene expression between pseudophakic bullous keratopathy and normal corneas (Mann–Whitney U test, p=0.0107).
See this image and copyright information in PMC

References

    1. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Wu RR, Ninomiya Y, Sado Y, Maguen E, Nesburn AB, Kenney MC. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996;37:997–1007. - PubMed
    1. Kenney MC, Atilano SR, Zorapapel N, Holguin B, Gaster RN, Ljubimov AV. Altered expression of aquaporins in bullous keratopathy and Fuchs’ dystrophy corneas. J Histochem Cytochem. 2004;52:1341–50. - PubMed
    1. Rosenbaum JT, Planck ST, Huang XN, Rich L, Ansel JC. Detection of mRNA for the cytokines, interleukin-l alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci. 1995;36:2151–5. - PubMed
    1. Ljubimov AV, Saghizadeh M, Spirin KS, Mecham RP, Sakai LY, Kenney MC. Increased expression of fibrillin-1 in human corneas with bullous keratopathy. Cornea. 1998;17:309–14. - PubMed
    1. Spirin KS, Ljubimov AV, Castellon R, Wiedoeft O, Marano M, Sheppard D, Kenney MC, Brown DJ. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40:3108–15. - PubMed

Publication types

Substances

LinkOut - more resources